Multiple Sclerosis Drug Copaxone Gets FDA “Black Box Warning” After Deaths From Allergic Reactions
Potentially deadly allergic reactions from Copaxone use can occur at least a year after starting treatment, the agency warns.
January 23, 2025 By: Martha Garcia
Potentially deadly allergic reactions from Copaxone use can occur at least a year after starting treatment, the agency warns.
The number of Suboxone lawsuits is expected to surge once again this summer, before a potential statute of limitations deadline in June 2025, for claims from states with a three-year statute of limitations.
A federal judge has reappointed a group of attorneys to plaintiff leadership positions in infant formula NEC litigation, just as the first cases are being prepared for trial.
Diabetes drug caused severe injuries, resulting in reduced kidney function and permanent injuries, according to an Ozempic stomach paralysis lawsuit.
"*" indicates required fields